Results 91 to 100 of about 719 (136)

Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy. [PDF]

Nutrients
Nuti R, Gennari L, Cavati G, Caffarelli C, Frediani B, Gonnelli S, Catalano A, Francucci CM, Laurentaci C, Letizia Mauro G, Malavolta N, Mazzantini M, Minisola G, Russo R, Sabatino P, Pinto M, Salomone S, Tei L, Vescini F, Xourafa A, Cartocci A, Lo Conte S, Merlotti D.   +22 more
europepmc   +1 more source

Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction. [PDF]

Oncologist
Chung V, Alistar A, Becerra C, Kasi A, Borazanci E, Jameson GS, Roe DJ, Wertheim BC, Cridebring D, Truitt M, Downes M, Barrett MT, Korn R, Lee K, Han H, Evans R, Von Hoff DD.   +16 more
europepmc   +1 more source

Vitamin D supplementation during pregnancy and maternal and neonatal outcomes: results from a quantitative umbrella meta-analysis. [PDF]

BMC Pregnancy Childbirth
Lin L, Zhu Q, Xiao Y, Zhang X.
europepmc   +1 more source

An Adapted Questionnaire Tailored for Assessing the Risk of Vitamin D Deficiency in Children That Is Proving Useful in Guiding Clinical Interventions. [PDF]

Nutrients
Calcaterra V, Cena H, De Giuseppe R, Biino G, Grazi R, Manuelli M, Zanelli S, Tagi V, Vincenti A, Zuccotti G, Fabiano V.   +10 more
europepmc   +1 more source

Paricalcitol Has a Potent Anti-Inflammatory Effect in Rat Endothelial Denudation-Induced Intimal Hyperplasia. [PDF]

Int J Mol Sci
Baeza C, Pintor-Chocano A, Carrasco S, Sanz A, Ortiz A, Sanchez-Niño MD.   +5 more
europepmc   +1 more source

Vitamin D supplementation for tuberculosis prevention: A meta-analysis. [PDF]

Biomol Biomed
Liu S, Lin T, Pan Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ergocalciferol and Cholecalciferol in CKD

American Journal of Kidney Diseases, 2012
The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological replacement with active vitamin D therefore has been a cornerstone of secondary hyperparathyroidism therapy in the end-stage renal disease population treated by long-term dialysis.
Sagar U, Nigwekar, Ishir, Bhan, Ravi, Thadhani   +2 more
openaire   +2 more sources

Ergocalciferol

Reactions Weekly, 2021
  +4 more sources

Ergocalciferol

Reactions Weekly, 2017
openaire   +2 more sources